215 related articles for article (PubMed ID: 24969360)
1. Understanding the etiology and management of HIV-associated peripheral neuropathy.
Stavros K; Simpson DM
Curr HIV/AIDS Rep; 2014 Sep; 11(3):195-201. PubMed ID: 24969360
[TBL] [Abstract][Full Text] [Related]
2. Managing HIV peripheral neuropathy.
Gonzalez-Duarte A; Cikurel K; Simpson DM
Curr HIV/AIDS Rep; 2007 Aug; 4(3):114-8. PubMed ID: 17883996
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of HIV-associated neuropathy.
Gonzalez-Duarte A; Robinson-Papp J; Simpson DM
Neurol Clin; 2008 Aug; 26(3):821-32, x. PubMed ID: 18657728
[TBL] [Abstract][Full Text] [Related]
4. Peripheral neuropathy in HIV: an analysis of evidence-based approaches.
Nicholas PK; Corless IB; Evans LA
J Assoc Nurses AIDS Care; 2014; 25(4):318-29. PubMed ID: 24698331
[TBL] [Abstract][Full Text] [Related]
5. HIV-related neuropathy: current perspectives.
Schütz SG; Robinson-Papp J
HIV AIDS (Auckl); 2013 Sep; 5():243-51. PubMed ID: 24049460
[TBL] [Abstract][Full Text] [Related]
6. Controlling neuropathic pain in HIV.
Verma S; Estanislao L; Mintz L; Simpson D
Curr HIV/AIDS Rep; 2004 Sep; 1(3):136-41. PubMed ID: 16091234
[TBL] [Abstract][Full Text] [Related]
7. Peripheral neuropathy in HIV patients on antiretroviral therapy: Does it impact function?
Dudley MT; Borkum M; Basera W; Wearne N; Heckmann JM
J Neurol Sci; 2019 Nov; 406():116451. PubMed ID: 31521960
[TBL] [Abstract][Full Text] [Related]
8. Risk modifiers for peripheral sensory neuropathy in HIV infection/AIDS.
Lopez OL; Becker JT; Dew MA; Caldararo R
Eur J Neurol; 2004 Feb; 11(2):97-102. PubMed ID: 14748769
[TBL] [Abstract][Full Text] [Related]
9. HIV peripheral neuropathy.
Gabbai AA; Castelo A; Oliveira AS
Handb Clin Neurol; 2013; 115():515-29. PubMed ID: 23931799
[TBL] [Abstract][Full Text] [Related]
10. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.
Ellis RJ; Rosario D; Clifford DB; McArthur JC; Simpson D; Alexander T; Gelman BB; Vaida F; Collier A; Marra CM; Ances B; Atkinson JH; Dworkin RH; Morgello S; Grant I;
Arch Neurol; 2010 May; 67(5):552-8. PubMed ID: 20457954
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
Simpson DM; Gazda S; Brown S; Webster LR; Lu SP; Tobias JK; Vanhove GF;
J Pain Symptom Manage; 2010 Jun; 39(6):1053-64. PubMed ID: 20538187
[TBL] [Abstract][Full Text] [Related]
12. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment.
Wulff EA; Wang AK; Simpson DM
Drugs; 2000 Jun; 59(6):1251-60. PubMed ID: 10882161
[TBL] [Abstract][Full Text] [Related]
13. Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy.
Shikuma CM; Bennett K; Ananworanich J; Gerschenson M; Teeratakulpisarn N; Jadwattanakul T; DeGruttola V; McArthur JC; Ebenezer G; Chomchey N; Praihirunkit P; Hongchookiat P; Mathajittiphun P; Nakamoto B; Hauer P; Phanuphak P; Phanuphak N;
J Neurovirol; 2015 Oct; 21(5):525-34. PubMed ID: 26002840
[TBL] [Abstract][Full Text] [Related]
14. Peripheral neuropathy in HIV disease.
Markarian Y; Wulff EA; Simpson DM
AIDS Clin Care; 1998 Dec; 10(12):89-91, 93, 98. PubMed ID: 11366069
[TBL] [Abstract][Full Text] [Related]
15. HIV neuropathy.
Kaku M; Simpson DM
Curr Opin HIV AIDS; 2014 Nov; 9(6):521-6. PubMed ID: 25275705
[TBL] [Abstract][Full Text] [Related]
16. NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
Simpson DM; Brown S; Tobias JK; Vanhove GF;
Clin J Pain; 2014 Feb; 30(2):134-42. PubMed ID: 23446088
[TBL] [Abstract][Full Text] [Related]
17. HIV peripheral neuropathy: pathophysiology and clinical implications.
Dorsey SG; Morton PG
AACN Clin Issues; 2006; 17(1):30-6. PubMed ID: 16462406
[TBL] [Abstract][Full Text] [Related]
18. Infectious neuropathy.
de Freitas MR
Curr Opin Neurol; 2007 Oct; 20(5):548-52. PubMed ID: 17885443
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals.
Shurie JS; Deribew A
Ethiop Med J; 2010 Apr; 48(2):85-93. PubMed ID: 20608012
[TBL] [Abstract][Full Text] [Related]
20. Measures of small-fiber neuropathy in HIV infection.
Boger MS; Hulgan T; Haas DW; Mitchell V; Smith AG; Singleton JR; Peltier AC
Auton Neurosci; 2012 Jul; 169(1):56-61. PubMed ID: 22542355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
